Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Revenue
Annual & quarterly revenue history · segment & region breakdown
RCDTF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsRecordati Industria Chimica e Farmaceutica S.p.A. trailing twelve-month (TTM) revenue is $2.65B, an increase of 11.82% year-over-year from $2.62B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $2.62B | +$0.28B | +11.82% |
| 2024-12-31 | $2.34B | +$0.26B | +12.45% |
| 2023-12-31 | $2.08B | +$0.23B | +12.36% |
| 2022-12-31 | $1.85B | +$0.27B | +17.29% |
| 2021-12-31 | $1.58B | +$0.13B | +9.06% |
| 2020-12-31 | $1.45B | -$0.03B | -2.23% |
| 2019-12-31 | $1.48B | +$0.13B | +9.59% |
| 2018-12-31 | $1.35B | +$0.06B | +4.98% |
| 2017-12-31 | $1.29B | +$0.13B | +11.63% |
| 2016-12-31 | $1.15B | +$0.11B | +10.14% |
Compare revenue vs peers
Drug Manufacturers - GeneralCompare RCDTF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Recordati Industria Chimica e Farmaceutica S.p.A. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Recordati Industria Chimica e Farmaceutica S.p.A. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in EUR.
Data sourced from Recordati Industria Chimica e Farmaceutica S.p.A.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
RCDTF revenue · 4 questionsRCDTF's trailing twelve-month (TTM) revenue is $2.65B. That is an increase of 11.82% year-over-year from $2.62B in FY2025.
▸ Source: FMP · Recordati Industria Chimica e Farmaceutica S.p.A. SEC filings · GAAP · Recordati Industria Chimica e Farmaceutica S.p.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026